Christopher Bowden
2017
In 2017, Christopher Bowden earned a total compensation of $2.3M as Chief Medical Officer at Agios Pharmaceuticals, a 32% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $233,571 |
---|---|
Option Awards | $1,639,353 |
Salary | $449,174 |
Other | $8,710 |
Total | $2,330,808 |
Bowden received $1.6M in option awards, accounting for 70% of the total pay in 2017.
Bowden also received $233.6K in non-equity incentive plan, $449.2K in salary and $8.7K in other compensation.
Rankings
In 2017, Christopher Bowden's compensation ranked 4,774th out of 14,666 executives tracked by ExecPay. In other words, Bowden earned more than 67.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,774 | 67th |
Manufacturing | 1,692 | 71st |
Chemicals And Allied Products | 496 | 76th |
Drugs | 382 | 78th |
Pharmaceutical Preparations | 303 | 77th |
Bowden's colleagues
We found four more compensation records of executives who worked with Christopher Bowden at Agios Pharmaceuticals in 2017.
News
Agios Pharmaceuticals CEO Jacqualyn Fouse's 2021 pay slips 14% to $6.5M
April 28, 2022
Agios Pharmaceuticals CEO Jacqualyn Fouse's 2020 pay falls 54% to $7.6M
April 8, 2021
Agios Pharmaceuticals CEO Jacqualyn Fouse receives $17M in 2019
April 16, 2020
Agios Pharmaceuticals CEO David Schenkein's 2018 pay jumps 37% to $8.2M
April 18, 2019